Has Reed Quinn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $87,986 in general payments to Reed Quinn, MD across 152 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reed Quinn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reed Quinn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reed Quinn, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Greeley, CONPI 1659382653

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Livanova USA, Inc. at 47.3% of the total. Reporting peaked in 2019 at $33,535 and has fallen 69.3% since, to $10,293 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,986in general payments, 2019–2025

Across 152 payments — averaging $578.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$42K
Corcym Inc$24K
Artivion, Inc.$13K
Edwards Lifesciences$4K
Atricure, Inc.$2K
Abbott$2K
plus $2K from 6 others

$75,847in research payments, 2019–2025

Across 32 payments — averaging $2370.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Livanova USA, Inc.$42K
Artivion, Inc.$33K
Corcym Inc$2K

What the payments were for

Royalty or licence$7,2688%
Consulting fees$23,20026%
Speaking & faculty fees$42,23048%
Travel & lodging$11,14313%
Food & beverage$4,1445%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	73	$41,648
Corcym Inc	28	$24,075
Artivion, Inc.	7	$13,446
Edwards Lifesciences	4	$3,634
Atricure, Inc.	7	$1,529
Abbott	21	$1,517
LSI Solutions Inc	1	$711
JACE Medical LLC	2	$700
Abiomed	2	$246
Medtronic	3	$233
Synthes USA Products LLC	1	$192
Johnson & Johnson(2 entities)	3	$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Perceval$58,823
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$12,446
Memo4D$5,249
ATRICURE ATRICLIP LAA EXCLUSION$822
RAM$711
COR KNOT$711
On-X$663
Epic$658
COREVALVE EVOLUT R$158
BIOGLUE SURGICAL ADHESIVE$148
AMDS-Ascyrus Medical$148
PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM$148
Jotec Products$148
CONNECT$126
Impella$107
MitraClip$103

How this compares

$87,986 in reported general payments places this provider in the 90th percentile of 72 thoracic surgery (cardiothoracic vascular surgery) providers in Colorado.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Colorado →

Medicare billing

Part B allowed, 2024

$192,138

Medicare patients

190

Services billed

413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Chloride	12	$34

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Greeley

Michael RobichGreeley$43K
Jason TchengGreeley$28K
Kenneth RichardsGreeley$1K
Hao PanLoveland$243K
Patrick RudersdorfLakewood$235K
Robert MeguidAurora$114K
Boris SepesiEnglewood$113K
Thomas ReeceAurora$110K
Joseph ClevelandAurora$85K
Jay PalAurora$79K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →